SG

Sharad Gautam Avhad

Director Director DIN 08957994
DIN 08957994 First appointment Nov 2020 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Nov 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Sharad Gautam Avhad

Data last updated:

Sharad Gautam Avhad has 5 years in corporate governance. Formerly with 1 company, such as Bionectar Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations.

DIN 08957994
Primary Designation Director
First Appointment 11 Nov 2020
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bionectar Healthcare Private Limited U33200PN2020PTC195936
Director11 Nov 20202020₹28.3 Lakh (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bionectar Healthcare Private Limited
Premium access

Shareholding and investment profile for Sharad Gautam Avhad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharad Gautam Avhad

Sharad Gautam Avhad has 5 years in corporate governance. Formerly with 1 company, such as Bionectar Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations.

Sharad Gautam Avhad has expertise in Healthcare.

Sharad Gautam Avhad has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available